These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
263 related articles for article (PubMed ID: 7798333)
1. Benzodiazepine receptor quantification in vivo in humans using [11C]flumazenil and PET: application of the steady-state principle. Lassen NA; Bartenstein PA; Lammertsma AA; Prevett MC; Turton DR; Luthra SK; Osman S; Bloomfield PM; Jones T; Patsalos PN J Cereb Blood Flow Metab; 1995 Jan; 15(1):152-65. PubMed ID: 7798333 [TBL] [Abstract][Full Text] [Related]
2. Measurement of benzodiazepine receptor number and affinity in humans using tracer kinetic modeling, positron emission tomography, and [11C]flumazenil. Price JC; Mayberg HS; Dannals RF; Wilson AA; Ravert HT; Sadzot B; Rattner Z; Kimball A; Feldman MA; Frost JJ J Cereb Blood Flow Metab; 1993 Jul; 13(4):656-67. PubMed ID: 8391018 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of benzodiazepine receptors in live Papio papio baboons using positron emission tomography. Brouillet E; Chavoix C; Khalili-Varasteh M; Bottlaender M; Hantraye P; Yorke JC; Maziere M Mol Pharmacol; 1990 Oct; 38(4):445-50. PubMed ID: 2172764 [TBL] [Abstract][Full Text] [Related]
4. Measurement of GABAA receptor binding in vivo with [11C]flumazenil: a test-retest study in healthy subjects. Salmi E; Aalto S; Hirvonen J; Långsjö JW; Maksimow AT; Oikonen V; Metsähonkala L; Virkkala J; Någren K; Scheinin H Neuroimage; 2008 Jun; 41(2):260-9. PubMed ID: 18411060 [TBL] [Abstract][Full Text] [Related]
5. Modeling analysis of [11C]flumazenil kinetics studied by PET: application to a critical study of the equilibrium approaches. Delforge J; Syrota A; Bottlaender M; Varastet M; Loc'h C; Bendriem B; Crouzel C; Brouillet E; Maziere M J Cereb Blood Flow Metab; 1993 May; 13(3):454-68. PubMed ID: 8478404 [TBL] [Abstract][Full Text] [Related]
6. Parametric images of benzodiazepine receptor concentration using a partial-saturation injection. Delforge J; Spelle L; Bendriem B; Samson Y; Syrota A J Cereb Blood Flow Metab; 1997 Mar; 17(3):343-55. PubMed ID: 9119907 [TBL] [Abstract][Full Text] [Related]
7. Quantification of human opiate receptor concentration and affinity using high and low specific activity [11C]diprenorphine and positron emission tomography. Sadzot B; Price JC; Mayberg HS; Douglass KH; Dannals RF; Lever JR; Ravert HT; Wilson AA; Wagner HN; Feldman MA J Cereb Blood Flow Metab; 1991 Mar; 11(2):204-19. PubMed ID: 1847703 [TBL] [Abstract][Full Text] [Related]
8. Neuroreceptor quantitation in vivo by the steady-state principle using constant infusion or bolus injection of radioactive tracers. Lassen NA J Cereb Blood Flow Metab; 1992 Sep; 12(5):709-16. PubMed ID: 1506439 [TBL] [Abstract][Full Text] [Related]
9. [18F]flumazenil binding to central benzodiazepine receptor studies by PET--quantitative analysis and comparisons with [11C]flumazenil. Odano I; Halldin C; Karlsson P; Varrone A; Airaksinen AJ; Krasikova RN; Farde L Neuroimage; 2009 Apr; 45(3):891-902. PubMed ID: 19136064 [TBL] [Abstract][Full Text] [Related]
10. Quantification of muscarinic cholinergic receptors with [11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. Zubieta JK; Koeppe RA; Mulholland GK; Kuhl DE; Frey KA J Cereb Blood Flow Metab; 1998 Jun; 18(6):619-31. PubMed ID: 9626186 [TBL] [Abstract][Full Text] [Related]
11. [18F]Fluoroethylflumazenil: a novel tracer for PET imaging of human benzodiazepine receptors. Gründer G; Siessmeier T; Lange-Asschenfeldt C; Vernaleken I; Buchholz HG; Stoeter P; Drzezga A; Lüddens H; Rösch F; Bartenstein P Eur J Nucl Med; 2001 Oct; 28(10):1463-70. PubMed ID: 11685488 [TBL] [Abstract][Full Text] [Related]
12. Cerebral benzodiazepine receptor binding in vivo in patients with recurrent hepatic encephalopathy. Macdonald GA; Frey KA; Agranoff BW; Minoshima S; Koeppe RA; Kuhl DE; Shulkin BL; Lucey MR Hepatology; 1997 Aug; 26(2):277-82. PubMed ID: 9252134 [TBL] [Abstract][Full Text] [Related]
13. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain. Frey KA; Holthoff VA; Koeppe RA; Jewett DM; Kilbourn MR; Kuhl DE Ann Neurol; 1991 Nov; 30(5):663-72. PubMed ID: 1662476 [TBL] [Abstract][Full Text] [Related]
14. Graphical analysis of reversible radioligand binding from time-activity measurements applied to [N-11C-methyl]-(-)-cocaine PET studies in human subjects. Logan J; Fowler JS; Volkow ND; Wolf AP; Dewey SL; Schlyer DJ; MacGregor RR; Hitzemann R; Bendriem B; Gatley SJ J Cereb Blood Flow Metab; 1990 Sep; 10(5):740-7. PubMed ID: 2384545 [TBL] [Abstract][Full Text] [Related]
15. [11C]flumazenil metabolite measurement in plasma is not necessary for accurate brain benzodiazepine receptor quantification. Sanabria-Bohórquez SM; Labar D; Levêque P; Bol A; De Volder AG; Michel C; Veraart C Eur J Nucl Med; 2000 Nov; 27(11):1674-83. PubMed ID: 11105824 [TBL] [Abstract][Full Text] [Related]
16. Comparison of two compartmental models for describing receptor ligand kinetics and receptor availability in multiple injection PET studies. Morris ED; Alpert NM; Fischman AJ J Cereb Blood Flow Metab; 1996 Sep; 16(5):841-53. PubMed ID: 8784229 [TBL] [Abstract][Full Text] [Related]